Cancer Prevention and Control Research


The overall goal of the Division of Cancer Prevention and Control is to conduct research to reduce the incidence, mortality and morbidity of cancer. The Division of Cancer Prevention and Control focuses on research across the cancer control continuum, from etiology through survivorship, includes a multi-level focus, from biology to policy, and has cross-cutting themes of underserved/minority populations, communication research, tobacco use and toxicity (including regulatory science) and behavioral strategies that capitalize on our members’ strengths, such as epidemiology, biology and behavior. In addition, many of our projects include trans-disciplinary research teams to better understand and address research aims.

Research Aims

The Division of Cancer Prevention and Control has three specific aims:

Aim 1: To identify molecular, genetic, and behavioral factors related to cancer incidence and mortality.


Research in this aim focuses on etiological observational studies of risk, specifically related to molecular, genetic and behavioral risk factors (tobacco, risky behaviors, diet/physical activity/obesity; and HPV risk and vaccination). Much of our research identifies the causes of disparities within our catchment area.

Aim 2: To develop and test behavioral interventions to prevent or detect cancer early.


Within this aim, researchers are focused on behavioral interventions as a way to prevent and/or reduce risk for developing cancer. Themes include tobacco, HPV vaccine promotion, diet/exercise/obesity, early detection and follow-up after abnormal screenings. Many projects address the needs of our catchment area in terms of cancers with high incidence/mortality (e.g., lung and colorectal cancer) or high-risk behaviors (e.g., smoking and lack of HPV vaccination).

Aim 3: To assess and intervene on issues of cancer survivorship.


This aim focuses on both observational and interventional studies among cancer patients and survivors, with many studies including biologic/mechanistic components.  These studies utilize the resources of our patient populations, national cooperative groups, and/or the Women’s Health Initiative (WHI) populations.


Contact the Division

Division Administrator:
Sarah Wilkins

1590 N High St
Suite 525
Columbus, OH 43201

Phone: 614-366-4641
sarah.wilkins@osumc.edu

Search for Clinical Trials